Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)
Sequential Therapy With JX-594, A Targeted Oncolytic Poxvirus, Followed by Sorafenib in Hepatocellular Carcinoma: Preclinical and Clinical Demonstration of Combination Efficacy
Julia Rintoul, 김미경, 이유경, 우현영, Kelley Parato, 오성용, Theresa Falls, Theresa Hickman, 이병건, John C Bell, David H Kirn, 황태호, Jeong Heo, Caroline J Breitbach, Anne Moon, Rick Patt, Chang Won Kim
MOLECULAR THERAPY, 2011
104
Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma
Clinicopathologic significance of ERCC1, thymidylate synthase and glutathione S-transferase P1 expression for advanced gastric cancer patients receiving adjuvant 5-FU and cisplatin chemotherapy
권경아, 장진석, 김수진, 김효진, 오성용, 김민찬, 김기한, 권혁찬, 김성현, 이수이
BIOMARKERS, 2011
106
Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone